Bremelanotide

Bremelanotide

Bremelanotide is an oligopeptide.

MolecularFormula	C50H68N14O10
MolecularWeight	1025.2
IUPACName	(3S,6S,9R,12S,15S,23S)-15-[[(2S)-2-acetamidohexanoyl]amino]-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexazacyclotricosane-23-carboxylic acid

• Bremelanotide
• 189691-06-3
• Bremelanotida
• 6Y24O4F92S
• PT-141 FREE BASE
• PT 141
• (3S,6S,9R,12S,15S,23S)-15-[[(2S)-2-acetamidohexanoyl]amino]-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexazacyclotricosane-23-carboxylic acid
• DTXSID40893711
• L-Lysine, N-acetyl-L-norleucyl-L-alpha-aspartyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophyl-, (2->7)-lactam
• N-Acetyl-L-2-aminohexanoyl-L-alpha-aspartyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophyl-L-lysine-(2->7)-lactam
• Bremelanotidum
• (3S,6S,9R,12S,15S,23S)-15-(((2S)-2-acetamidohexanoyl)amino)-9-benzyl-6-(3-(diaminomethylideneamino)propyl)-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexazacyclotricosane-23-carboxylic acid
• RefChem:58355
• DTXCID701323799
• PT-141
• Bremelanotide [USAN:INN]
• UNII-6Y24O4F92S
• PT141
• Vyleesi (TN)
• (3S,6S,9R,12S,15S,23S)-12-((1H-imidazol-5-yl)methyl)-3-((1H-indol-3-yl)methyl)-15-((S)-2-acetamidohexanamido)-9-benzyl-6-(3-guanidinopropyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexaazacyclotricosane-23-carboxylic acid
• Bremelanotide?
• Bremelanotide PT 141
• Bremelanotide, PT-141
• N-Acetyl-L-norleucyl-L-alpha-aspartyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophyl-L-lysine (2-7)-lactam
• BREMELANOTIDE [MI]
• BREMELANOTIDE [INN]
• PT-141 (Bremelanotide)
• Bremelanotide (USAN/INN)
• BREMELANOTIDE [WHO-DD]
• orb1987357
• CHEMBL2070241
• SCHEMBL13574795
• SCHEMBL20337333
• SCHEMBL29405727
• SCHEMBL29575745
• GTPL10408
• CHEBI:177849
• BDBM50389769
• AKOS005145807
• AT41880